Efficient correction of Duchenne muscular dystrophy mutations by SpCas9 and dual gRNAs

CRISPR gene therapy is one promising approach for treatment of Duchenne muscular dystrophy (DMD), which is caused by a large spectrum of mutations in the dystrophin gene. To broaden CRISPR gene editing strategies for DMD treatment, we report the efficient restoration of dystrophin expression in indu...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Xi, Zhao, Xiaoying, Pan, Xiaoguang, Dong, Zhanying, Yu, Jiaying, Li, Siyuan, Liang, Xue, Han, Peng, Qu, Kunli, Jensen, Jonas Brorson, Farup, Jean, Wang, Fei, Petersen, Trine Skov, Bolund, Lars, Teng, Huajing, Lin, Lin, Luo, Yonglun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039775/
https://www.ncbi.nlm.nih.gov/pubmed/33868784
http://dx.doi.org/10.1016/j.omtn.2021.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039775/
https://www.ncbi.nlm.nih.gov/pubmed/33868784
http://dx.doi.org/10.1016/j.omtn.2021.03.005

Ejemplares similares